Device and method for preventing hypoglycemia
First Claim
8-1. The device of claim 21, wherein if BBG>
- TBG and RI>
CB, then CC=CIR*(RI+((TBG−
BBG)/IS)).
2 Assignments
0 Petitions
Accused Products
Abstract
A device and a method are provided that can be used for prevention of hypoglycemia. In one aspect, a device and a method for prevention of hypoglycemia can comprise receiving a target blood glucose (TBG) level corresponding to a desired level of glucose in a patient'"'"'s body during a fasting time period; receiving a bedtime blood glucose (BBG) level corresponding to the level of glucose in the patient'"'"'s body substantially at the beginning of the fasting time period; receiving a first set of parameters corresponding to a medical state of the patient; providing the levels of the TBG, BBG and the medical state of the patent to a therapeutic course of action determining means; and, providing means for administering the therapeutic course of action to the patient.
-
Citations
37 Claims
-
8-1. The device of claim 21, wherein if BBG>
- TBG and RI>
CB, then CC=CIR*(RI+((TBG−
BBG)/IS)).
- TBG and RI>
-
16. A method for preventing hypoglycemia comprising:
-
receiving a target blood glucose (TBG) level corresponding to a desired level of glucose in a patient'"'"'s body during a fasting time period; receiving a bedtime blood glucose (BBG) level corresponding to the level of glucose in the patient'"'"'s body substantially at the beginning of the fasting time period; receiving a first set of parameters comprising the patient'"'"'s insulin sensitivity (IS) and the patient'"'"'s carbohydrate to insulin ratio (CIR); providing the levels of the TBG, BBG and the first set of parameters to a therapeutic course of action determining means; and
,providing means for administering the therapeutic course of action to the patient. - View Dependent Claims (17, 18)
-
-
19. A device for preventing hypoglycemia comprising:
-
at least one module adapted for receiving a target blood glucose (TBG) level corresponding to a desired level of glucose in a patient'"'"'s body during a fasting time period; at least one module adapted for receiving a bedtime blood glucose (BBG) level corresponding to the level of glucose in the patient'"'"'s body substantially at the beginning of the fasting time period; at least one module adapted for receiving a first set of parameters comprising the patient'"'"'s insulin sensitivity (IS) and the patient'"'"'s carbohydrate to insulin ratio (CIR); at least one module adapted for determining a therapeutic course of action based on the levels of the TBG, BBG and the first set of parameters; and
,at least one module adapted for administering the therapeutic course of action to the patient. - View Dependent Claims (1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 36, 37)
-
-
33. A device for preventing hypoglycemia comprising:
-
means for receiving a target blood glucose (TBG) level corresponding to a desired level of glucose in a patient'"'"'s body during a fasting time period; means for receiving a bedtime blood glucose (BBG) level corresponding to the level of glucose in the patient'"'"'s body substantially at the beginning of the fasting time period; means for receiving a first set of parameters comprising the patient'"'"'s insulin sensitivity (IS) and the patient'"'"'s carbohydrate to insulin ratio (CIR); means for determining a therapeutic course of action using the levels of the TBG, BBG and the first set of parameters; and
,means for administering the therapeutic course of action to the patient. - View Dependent Claims (34, 35)
-
Specification